PDCD1 and neoplasm: Moreover, when CD8+ T cells cultured under normal conditions were co‐cultured with tumor cells, there was no significant increase in CD8+ T cell function in the CX4945 group, the anti‐PD‐1 therapy group, or the CX4945 plus anti‐PD‐1 therapy group compared to the control group.